Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Maintains Outperform on Salesforce, Lowers Price Target to $210

Cowen & Co. analyst J. Derrick Wood maintains Salesforce (NYSE:CRM) with a Outperform and lowers the price target from $225 to $210.
byBenzinga Newsdesk
August 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst J. Derrick Wood maintains Salesforce (NYSE:CRM) with a Outperform and lowers the price target from $225 to $210.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ardelyx Announces Acceptance Of New Drug Application For Tenapanor For Hyperphosphatemia In China; Triggers $2M Milestone Payment To Ardelyx Under The Terms Of The License Agreement Between Co And Shanghai Fosun Pharmaceutical Industrial Development C…

By Happy Mohamed
July 13, 8:06 AM
Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that

ARDX